Virus-induced Systemic Vasculitides: New Therapeutic Approaches
Author Information
Author(s): C GUILLEVIN
Primary Institution: Department of Internal Medicine, Hospital Cochin, AP-HP, Universite Rene Descartes-Paris V
Hypothesis
The best therapeutic strategy in virus-induced vasculitides should take into account the etiology of the disease and be adapted to the pathogenesis.
Conclusion
Combining antiviral treatments with plasma exchanges has proven effective in treating virus-induced vasculitides like polyarteritis nodosa and HIV-related vasculitis.
Supporting Evidence
- Antiviral treatments combined with plasma exchanges have been effective in polyarteritis nodosa.
- HIV-related vasculitis can be treated effectively without cytotoxic agents.
- Plasma exchanges improve outcomes in HCV-associated cryoglobulinemia, but relapses are frequent.
Takeaway
Doctors found that using antiviral drugs and a special blood treatment can help people with certain virus-related diseases that affect blood vessels.
Methodology
The study involved a combination of antiviral treatments and plasma exchanges for patients with virus-induced vasculitides.
Limitations
The effectiveness of antiviral drugs in treating HCV-related cryoglobulinemia is limited, and relapses are common.
Participant Demographics
Patients included those with polyarteritis nodosa related to hepatitis B virus and mixed cryoglobulinemia related to hepatitis C virus.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website